Skip to content

Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway (Onco-PREMs)

Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06356363
Acronym
OncoPREMs
Enrollment
500
Registered
2024-04-10
Start date
2024-06-01
Completion date
2025-11-01
Last updated
2024-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Oncology, oncology care pathway, patients' perception, questionnaire, psychometric validation

Brief summary

Healthcare systems are evolving, giving increasing prominence to the patient-centered model, accompanied by objective and perceived outcomes. PREMs (Patient Reported Experience Measures) are used to assess how patients feel about their experience of care. PREMs enable patients to take an active role in their own care, and enable healthcare establishments to identify areas for improvement that can be incorporated into their quality processes. In oncology, the collection of patient-perceived quality regarding their care pathway would enable better coordination of their care. While a few initiatives have emerged in the field of PREMs, the development of a reliable questionnaire assessing patient perception of their care pathway in oncology remains a challenge.

Detailed description

The aims of the study are to constitute a questionnaire to assess patients' perceptions of their oncology care pathway and to perform its psychometric validation.

Interventions

OTHERData collection

data collection

Sponsors

Université de Reims Champagne-Ardenne
CollaboratorOTHER
Institut Jean-Godinot
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* cancer patient * regardless of location or stage * Fluent in French * aged more than 18 years old * Agreeing to take part in the study

Exclusion criteria

* With an estimated life expectancy of less than 3 months * In remission, untreated or without follow-up for more than 12 months * Protected by law

Design outcomes

Primary

MeasureTime frameDescription
Psychometric validationDay 0Stastistical analysis to confirm the psychometric validation of the IGQ questionnaire

Contacts

Primary ContactBarbe Coralie, DR
coralie.barbe1@univ-reims.fr0326918822
Backup ContactGestonnairedu CURRS, Dr
currs@univ-reims.fr0326918822

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026